Skip to main content
Long COVID

Be part of groundbreaking Long COVID research from Scripps Research

We endeavor to conduct a portfolio of Long COVID clinical trials within our Long COVID Treatment Trial (LoCITT) program, operated by Scripps Research in partnership with CareEvolution and funded by the Schmidt Initiative for Long COVID (SILC). This work is crucial given the global burden of Long COVID, with over 400 million individuals affected, several mechanisms involved in contributing to over 200 symptoms, and no FDA approved treatments.

Current Studies

“The fact that it is being looked at is huge. This condition is scary because there are so many symptoms and doctors don’t know what to expect, so collecting this data is so important because it has the potential to be so impactful for so many people.”

Estela Mata
Long COVID user tester

About LoCITT

The Long COVID research program at Scripps has:

  • Remote participation options
  • Participants living in the U.S.
  • Real-world data collected via digital health tools

Private and Trusted

LoCITT is run by Scripps Research, a leading nonprofit academic institution with a focus on research and education in biomedical sciences. Our researchers lead breakthrough studies that address the world’s most pressing health concerns.

As a trusted nonprofit organization, your privacy is our priority. In order to protect you, your name and personal information are removed from your data prior to it reaching our researchers. 

Easy, Free and Convenient

If you live in the United States and have a smartphone, you can download the MyDataHelps™ app to participate.

Download App

Connect Devices

Share Health Records

Fill Out Surveys

Get Data and Recommendations

Join the Long COVID Treatment Trial (LoCITT) waitlist

We are beginning a waitlist of people who are interested in participating to contribute to the advancement of Long COVID and infection-associated chronic conditions research.

Join the LoCITT waitlist
Únase a la lista de espera de LoCITT

You can sign up to receive updates on our Long COVID clinical trials and be notified before a clinical trial launches.

You can be removed from the waitlist by:

  • Contacting the research team at longcovid@scripps.edu
  • You will no longer be contacted about new research opportunities

Join Our Early Experience Tester Program

We’re looking for volunteers to try out new features before they launch. Sign up to be among the first to explore the Long COVID Treatment Trial experience and help us make it better for everyone.

Sign Up

Contact Us

For questions regarding this program, please contact us by email at longcovid@scripps.edu.

News & Media

2025 Year in Review: Five insights we’re still thinking about
Scripps Research: Science Changing Life Podcast

Webinar: Long COVID Treatment Trial-Trizepatide (LoCITT-T): Study Update & Live Q&A (Dec. 17, 2025)
Scripps Research

Inside the GLP-1 Study for Long COVID, with lead scientist Dr Julia Vogel, Long Covid, MD Pod, Ep 61
LongCovidMD

Weight-Loss Drug Zepbound Is Being Tested as a Treatment for Long Covid
Wired

Dr. Julia Moore Vogel – Scripps Research – Visionary, Patient-Centric Health Research For All
Progress, Potential, and Possibilities

Scientists launch new trial for long COVID treatment
KPBS Midday Edition

Webinar: Long COVID Treatment Trial-Tirzepatide (LoCITT-T): Learn How to Participate From Home (Nov. 5, 2025)
Scripps Research

Researchers launch new study to test popular weight-loss drugs for long COVID treatment
WDIV Local 4 / ClickOnDetroit

Researchers at Scripps test weight-loss drug for long COVID relief
41NBC Georgia

Scripps researchers investigate whether weight loss drugs could improve long COVID symptoms
KYMA Arizona

Tuesday’s Daily Dose with Monica Robins: Veterans face skin cancer risk, long COVID drug trial launches and measles cases surge
WKYC Studios Ohio

We need more at-home clinical trials for Long COVID. Here’s how we designed the largest one yet.
The Sick Times

Obesity drug seen as effective for Long COVID, gets clinical trial
KPBS

Could GLP-1 weight loss drugs treat long-haul COVID
NBC 7 San Diego

Can a weight loss and diabetes drug treat Long COVID?
The San Diego Union-Tribune

Scripps Research scientists launch new digital clinical trial to test repurposed drug for Long COVID symptom relief
Scripps Research

Webinar: Introducing the Long COVID Treatment Trial (LoCITT)
Scripps Research

Remote Long COVID trial to evaluate repurposed drug across US
ContagionLive

“The field is coming of age”: Long COVID researchers gather in Santa Fe to foster collaboration
Sick Times

Long COVID patients can sign up for remote clinical trial notification
The Schmidt Initiative for Long COVID

The long haul: Personal and scientific insights into long COVID with Julia Moore Vogel
Scripps Research: Science Changing Life Podcast

Share